Mesenchymal stem cells offer a promising path forward in managing complex conditions that are often age-related. What makes MSCs unique and how do they compare to iPSCs?

Servier Pharmaceuticals Susan Pandya discusses how sponsors can translate a belief in patient centricity into action by creating more accessible, inclusive, and patient-friendly pathways to participation.

Technology holds incredible promise for transforming the life sciences industry—from accelerating drug discovery to improving clinical outcomes. However, achieving this transformation is more complex than simply adopting new tools. Real change […]

Jenn Azar explores the evolution of customer-centricity in the digital age, emphasizing the importance of personalization and the integration of technology to enhance customer relationships.

In an industry as dynamic and fast-evolving as life sciences, staying ahead requires living in the unknown. It’s a scary place to be—but it’s also where the most exciting possibilities […]

The life sciences industry is undergoing a profound transformation, driven by the unprecedented speed of asset discovery facilitated by advanced AI tools. As a CEO deeply embedded in the automation […]

AI readiness means integrating AI into strategy, operations, and culture—beyond just technology—by aligning people, processes, and long-term goals for lasting transformation.

Realizing the benefits of regenerative medicine will require a structural shift toward earlier detection and therapeutic intervention.

Recent developments, including a high-profile acquisition and key regulatory changes, point to a paradigm shift. Cell and gene therapy is becoming increasingly commercially viable, with the potential to improve the lives of millions.